Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545193 · ClinicalTrials.gov registry record
The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 300
- Enrollment target
NCT01545193: Completed study, sponsored by Endeavor Health.
NCT01545193 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01545193 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. However, it is possible that elderly surgical patients may exhibit a higher incidence of residual neuromuscular blockade. The aim of this clinical trial is to determine the incidence of residual neuromuscular blockade in a cohort of younger (ages 18-50) and older (ages 70-90) patients undergoing surgery and general anesthesia.
Primary Outcome
The TOF-Watch SX will be used to determine the incidence of residual neuromuscular blockade. The TOF-Watch SX consists of a nerve stimulator and a sensor to quantify the TOF ratio. Two consecutive responses to train-of-four (TOF) stimulation will be obtained, and the average of the two values recorded. If the measurements differ by greater than 10%, additional TOF ratios can be obtained (up to a total of 4 TOF values), and the closest two ratios averaged. The number of patients with TOF ratios \
Interventions
- OTHER Age and incidence of residual neuromuscular blockade
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-09 |
What the finished NCT01545193 record still lists
NCT01545193 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Age and incidence of residual neuromuscular blockade is the first listed.
NCT01545193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01545193 about?
NCT01545193 is a clinical study titled "The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade". Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. Howeve...
What is the current status of trial NCT01545193?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2011-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01545193?
The interventions under investigation include: Age and incidence of residual neuromuscular blockade (OTHER).
Who is sponsoring clinical trial NCT01545193?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia